Detalles de la búsqueda
1.
[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes.
Cancers (Basel);
13(20)2021 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34680243
2.
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [99mTc]Tc-DB4 and [111In]In-SG4 in Mice Treated with Entresto.
Pharmaceutics;
12(12)2020 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33256013
3.
[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.
Molecules;
25(15)2020 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32731473
4.
[99mTc]Tc-DGA1, a Promising CCK2R-Antagonist-Based Tracer for Tumor Diagnosis with Single-Photon Emission Computed Tomography.
Mol Pharm;
17(8): 3116-3128, 2020 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32568549
5.
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands.
Pharmaceutics;
12(6)2020 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32526874
6.
Comparative evaluation of the new GRPR-antagonist 111 In-SB9 and 111 In-AMBA in prostate cancer models: Implications of in vivo stability.
J Labelled Comp Radiopharm;
62(10): 646-655, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30963606
7.
Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses.
Pharmaceuticals (Basel);
12(1)2019 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30897789
8.
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair.
Molecules;
24(6)2019 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871262
9.
Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.
Bioconjug Chem;
29(5): 1774-1784, 2018 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29664606
10.
NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice.
Molecules;
22(11)2017 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29137110
11.
Novel bifunctional DATA chelator for quick access to site-directed PET 68Ga-radiotracers: preclinical proof-of-principle with [Tyr3]octreotide.
Dalton Trans;
46(42): 14584-14590, 2017 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28675208
12.
Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.
Nucl Med Biol;
52: 57-62, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28636973
13.
Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
J Nucl Med;
58(1): 75-80, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27493272
14.
(99m)Tc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice.
Nucl Med Biol;
43(6): 347-54, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27260775
15.
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary thyroid carcinoma patients.
Eur J Pharm Sci;
91: 236-42, 2016 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27185299
16.
Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor Phosphoramidon.
Cancer Biother Radiopharm;
31(1): 20-8, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26844849
17.
Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation.
EJNMMI Res;
6(1): 15, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26882895
18.
Use of the HPRT gene to study nuclease-induced DNA double-strand break repair.
Hum Mol Genet;
24(24): 7097-110, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26423459
19.
In vivo inhibition of neutral endopeptidase enhances the diagnostic potential of truncated gastrin (111)In-radioligands.
Nucl Med Biol;
42(11): 824-32, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26300210
20.
[111In-DOTA]LTT-SS28, a first pansomatostatin radioligand for in vivo targeting of somatostatin receptor-positive tumors.
J Med Chem;
57(15): 6564-71, 2014 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25007399
Resultados
1 -
20
de 20
1
Próxima >
>>